Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine
Globe Newswire10-01-2024, 10:15
Peyto Reports Record Profit and Cash Flow in 2022 9-03-2023, 07:43